Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users
Brief Summary: Cigarette smoking is very common in current and former injection drug users and is known to cause chronic lung diseases. Quitting smoking is proven to improve the health of people addicted to cigarettes. . Little information exists regarding the perceptions and characteristics of drug users regarding quitting smoking. Additionally, most programs designed to help people quit smoking are not very successful. One reason these programs may not work well is because it is difficult to motivate people to quit smoking. New methods of motivating changes in behavior include small monetary payments for healthy behavior and reporting breathing tests with the concept of "lung age," which is the age of an average healthy person with similar breathing test results. For example, a health care provider can report results as "Although you are 50 years old, you have the lungs for a 70 year old". In this proposal, the investigators plan to first explore the beliefs and characteristics of current and former injection drug users and how they are related to quitting smoking. The investigators then plan to study whether the use of two new methods of motivation increases the chances that this group will stop smoking.


Options:
A: Intervention Type: BEHAVIORAL; Name: Financial incentives; Assigned to Arm(s): N/A
B: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: Individual Rewards; Type: EXPERIMENTAL; Interventions: Behavioral: Individual Rewards | Arm Label: Fixed Deposits; Type: EXPERIMENTAL; Interventions: Behavioral: Fixed Deposits | Arm Label: Competitive Deposits (Pari-Mutuel); Type: EXPERIMENTAL; Interventions: Behavioral: Competitive Deposits (Pari-Mutuel) | Arm Label: Collaborative Rewards; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative Rewards | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care | Intervention Type: BEHAVIORAL; Name: Individual Rewards; Assigned to Arm(s): Individual Rewards | Intervention Type: BEHAVIORAL; Name: Fixed Deposits; Assigned to Arm(s): Fixed Deposits | Intervention Type: BEHAVIORAL; Name: Competitive Deposits (Pari-Mutuel); Assigned to Arm(s): Competitive Deposits (Pari-Mutuel) | Intervention Type: BEHAVIORAL; Name: Collaborative Rewards; Assigned to Arm(s): Collaborative Rewards
C: Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: Lung Age; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lung age | Arm Label: Contingency Management; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Contingency Management | Arm Label: Lung age + Contingency Management; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lung age + Contingency Management | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care | Intervention Type: BEHAVIORAL; Name: Lung age; Assigned to Arm(s): Lung Age | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): Contingency Management | Intervention Type: BEHAVIORAL; Name: Lung age + Contingency Management; Assigned to Arm(s): Lung age + Contingency Management
D: Arm Label: Phase 1: Standard of Care (A); Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: Brief Counseling | Arm Label: Phase 1: Standard of Care (B); Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: Brief Counseling, Behavioral: High-magnitude prize contingency management | Arm Label: Phase 2a Non-Responders (A); Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: Brief Counseling, Behavioral: Monitored support to quit smoking | Arm Label: Phase 2a: Non-Responders (B); Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: Monitored support to quit smoking, Behavioral: Prize contingency management for abstinence | Arm Label: Phase 2b: Responders (A); Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: No additional treatment | Arm Label: Phase 2b: Responders (B); Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: Monitored support to quit smoking, Behavioral: Low intensity prize contingency management | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): Phase 1: Standard of Care (A), Phase 1: Standard of Care (B), Phase 2a Non-Responders (A), Phase 2a: Non-Responders (B), Phase 2b: Responders (A), Phase 2b: Responders (B) | Intervention Type: BEHAVIORAL; Name: Brief Counseling; Assigned to Arm(s): Phase 1: Standard of Care (A), Phase 1: Standard of Care (B), Phase 2a Non-Responders (A) | Intervention Type: BEHAVIORAL; Name: High-magnitude prize contingency management; Assigned to Arm(s): Phase 1: Standard of Care (B) | Intervention Type: BEHAVIORAL; Name: Monitored support to quit smoking; Assigned to Arm(s): Phase 2a Non-Responders (A), Phase 2a: Non-Responders (B), Phase 2b: Responders (B) | Intervention Type: BEHAVIORAL; Name: No additional treatment; Assigned to Arm(s): Phase 2b: Responders (A) | Intervention Type: BEHAVIORAL; Name: Prize contingency management for abstinence; Assigned to Arm(s): Phase 2a: Non-Responders (B) | Intervention Type: BEHAVIORAL; Name: Low intensity prize contingency management; Assigned to Arm(s): Phase 2b: Responders (B)

Answer: C